Dengue virus infection induces interferon-lambda1 to facilitate cell migration

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hsu, Yu Lin ^a   Wang, Mei Yi ^b   Ho, Ling Jun ^c   Lai, Jenn Haung ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON-LAMBDA, HUMAN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; NITRILE; RECOMBINANT PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; SMALL INTERFERING RNA; SULFONE; TOLL LIKE RECEPTOR 3; VIRAL PROTEIN;

A-549 CELL LINE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CYTOLOGY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS LOAD;

A549 CELLS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CCL21; DENDRITIC CELLS; DENGUE; DENGUE VIRUS; EPITHELIAL CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERONS; NF-KAPPA B; NITRILES; RECEPTORS, CCR7; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SULFONES; TOLL-LIKE RECEPTOR 3; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84979516774     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24530     Document Type: Article

References (51)

1. Sharmin, S., Viennet, E., Glass, K. & Harley, D. The emergence of dengue in Bangladesh: epidemiology, challenges and future disease risk. Trans R Soc Trop Med Hyg 109, 619-627 (2015).
2. Laughlin, C. A. et al. Dengue research opportunities in the Americas. J Infect Dis 206, 1121-1127 (2012).
3. Paessler, S. & Walker, D. H. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8, 411-440 (2013).
4. Sadler, A. J. & Williams, B. R. Interferon-inducible antiviral effectors. Nat Rev Immunol 8, 559-568 (2008).
5. MacMicking, J. D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12, 367-382 (2012).
6. Kotenko, S. V. et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4, 69-77 (2003).
7. Egli, A. et al. Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus. J Infect Dis 210, 717-727 (2014).
8. Lazear, H. M., Nice, T. J. & Diamond, M. S. Interferon-lambda: Immune Functions at Barrier Surfaces and Beyond. Immunity 43, 15-28 (2015).
9. Mennechet, F. J. & Uze, G. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107, 4417-4423 (2006).
10. Durbin, R. K., Kotenko, S. V. & Durbin, J. E. Interferon induction and function at the mucosal surface. Immunol Rev 255, 25-39 (2013).
11. Mahlakoiv, T., Hernandez, P., Gronke, K., Diefenbach, A. & Staeheli, P. Leukocyte-derived IFN-alpha/beta and epithelial IFNlambda constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLos Pathog 11, e1004782, doi: 10.1371/journal.ppat.1004782 (2015).
12. Baldridge, M. T. et al. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 347, 266-269 (2015).
13. Odendall, C. et al. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol 15, 717-726 (2014).
14. Griffiths, S. J., Dunnigan, C. M., Russell, C. D. & Haas, J. G. The Role of Interferon-lambda Locus Polymorphisms in Hepatitis C and Other Infectious Diseases. J Innate Immun 7, 231-242 (2015).
15. Manuel, O. et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 211, 906-914 (2015).
16. Hermant, P. & Michiels, T. Interferon-lambda in the context of viral infections: production, response and therapeutic implications. J Innate Immun 6, 563-574 (2014).
17. Ho, L. J. et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166, 1499-1506 (2001).
18. Hsu, Y. L., Shi, S. F., Wu, W. L., Ho, L. J. & Lai, J. H. Protective Roles of Interferon-Induced Protein with Tetratricopeptide Repeats 3 (IFIT3) in Dengue Virus Infection of Human Lung Epithelial Cells. PLos One 8, e79518, doi: 10.1371/journal.pone.0079518 (2013).
19. Munoz-Jordan, J. L., Sanchez-Burgos, G. G., Laurent-Rolle, M. & Garcia-Sastre, A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 100, 14333-14338 (2003).
20. Acosta, E. G., Castilla, V. & Damonte, E. B. Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell Microbiol 11, 1533-1549 (2009).
21. Ioannidis, I., Ye, F., McNally, B., Willette, M. & Flano, E. Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol 87, 3261-3270 (2013).
22. Wu, W. L., Ho, L. J., Chang, D. M., Chen, C. H. & Lai, J. H. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol 39, 3413-3422 (2009).
23. Hsu, Y. L., Wang, M. Y., Ho, L. J., Huang, C. Y. & Lai, J. H. Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus. J Cell Mol Med 19, 1065-1076 (2015).
24. Palma-Ocampo, H. K. et al. Interferon lambda inhibits dengue virus replication in epithelial cells. Virol J 12, 150, doi: 10.1186/s12985-015-0383-4 (2015).
25. Liang, Z. et al. Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PLos One 6, e23346, doi: 10.1371/journal.pone.0023346 (2011).
26. Coccia, E. M. et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34, 796-805 (2004).
27. Iversen, M. B., Ank, N., Melchjorsen, J. & Paludan, S. R. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs. J Virol 84, 4579-4586 (2010).
28. Lee, H. C., Narayanan, S., Park, S. J., Seong, S. Y. & Hahn, Y. S. Transcriptional regulation of IFN-lambda genes in hepatitis C virusinfected hepatocytes via IRF-3.IRF-7.NF-kappaB complex. J Biol Chem 289, 5310-5319 (2014).
29. Chang, T. H. et al. Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-kappaB activation to downregulate cytokine production. PLos One 7, e41635, doi: 10.1371/journal.pone.0041635 (2012).
30. Banos-Lara Mdel, R. et al. Impact and regulation of lambda interferon response in human metapneumovirus infection. J Virol 89, 730-742 (2015).
31. Audry, M. et al. NEMO is a key component of NF-kappaB-and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus. J Allergy Clin Immunol 128, 610-617 e611-614, doi: 10.1016/j.jaci.2011.04.059 (2011).
32. Alcon, S. et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 40, 376-381 (2002).
33. Cheng, H. J. et al. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol Immunol 47, 398-406 (2009).
34. Avirutnan, P. et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med 207, 793-806 (2010).
35. Green, S. & Rothman, A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19, 429-436 (2006).
36. Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med 7, 304ra141, doi: 10.1126/scitranslmed.aaa3787 (2015).
37. Costa, S. M. et al. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the nonstructural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine 24, 195-205 (2006).
38. Amorim, J. H. et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine 30, 837-845 (2012).
39. Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med 7, 304ra142, doi: 10.1126/scitranslmed.aaa3863 (2015).
40. Chen, J., Ng, M. M. & Chu, J. J. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection. PLos Pathog 11, e1005053, doi: 10.1371/journal.ppat.1005053 (2015).
41. Schmid, M. A., Diamond, M. S. & Harris, E. Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front Immunol 5, 647, doi: 10.3389/fimmu.2014.00647 (2014).
42. Hinz, M. et al. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605-617 (2002).
43. Mburu, Y. K. et al. Chemokine receptor 7 (CCR7) gene expression is regulated by NF-kappaB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN). J Biol Chem 287, 3581-3590 (2012).
44. Mucha, J., Majchrzak, K., Taciak, B., Hellmen, E. & Krol, M. MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-lambda) signaling. PLos One 9, e103249, doi: 10.1371/journal.pone.0103249 (2014).
45. De La Cruz Hernandez, S. I. et al. A strong interferon response correlates with a milder dengue clinical condition. J Clin Virol 60, 196-199 (2014).
46. Pech Torres, R. E., Cedillo Rivera, R. M., Lorono Pino, M. A. & Sanchez Burgos, G. G. Serum levels of IFN-beta are associated with days of evolution but not with severity of dengue. J Med Virol 88, 395-399 (2016).
47. Morrison, J., Aguirre, S. & Fernandez-Sesma, A. Innate immunity evasion by Dengue virus. Viruses 4, 397-413 (2012).
48. Ho, L. J. et al. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 174, 8163-8172 (2005).
49. Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
50. Maringer, K. & Fernandez-Sesma, A. Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection. Cytokine Growth Factor Rev 25, 669-679 (2014).
51. Aguirre, S. et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLos Pathog 8, e1002934, doi: 10.1371/journal.ppat.1002934 (2012).